No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Hims & Hers Health (HIMS) and MannKind (MNKD)
MannKind to Present at 2024 UBS Healthcare Conference
Express News | MannKind Corp - No Serious Adverse Events or Study Drug Discontinuation
Express News | MannKind Corp - Expects FDA Meeting in 1H 2025 to Advance Mnkd-201
Express News | MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
Earnings Preview: MannKind to Report Financial Results Post-market on November 07
$MannKind(MNKD.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $MannKind(MNKD.US)$ to post revenue of USD74.49M for 2024Q3, up 45.33